Lithium sulfate structure 
             | 
        Common Name | Lithium sulfate | ||
|---|---|---|---|---|
| CAS Number | 10377-48-7 | Molecular Weight | 109.945 | |
| Density | 2.22 g/mL at 25 °C(lit.) | Boiling Point | 330ºC at 760mmHg | |
| Molecular Formula | Li2O4S | Melting Point | 845 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol | 
             
            
            GHS07  | 
        Signal Word | Warning | |
| Name | lithium sulfate | 
|---|---|
| Synonym | More Synonyms | 
| Density | 2.22 g/mL at 25 °C(lit.) | 
|---|---|
| Boiling Point | 330ºC at 760mmHg | 
| Melting Point | 845 °C(lit.) | 
| Molecular Formula | Li2O4S | 
| Molecular Weight | 109.945 | 
| Exact Mass | 109.983734 | 
| PSA | 88.64000 | 
| Vapour Pressure | 3.35E-05mmHg at 25°C | 
| Water Solubility | 25.7 g/100 mL (25 ºC) | 
                                    CHEMICAL IDENTIFICATION
 
 
 
 
 
 
 HEALTH HAZARD DATAACUTE TOXICITY DATA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MUTATION DATA
 
 
 
  | 
                            
| Symbol | 
                                    
                                     
                                    
                                    GHS07  | 
                            
|---|---|
| Signal Word | Warning | 
| Hazard Statements | H302-H319 | 
| Precautionary Statements | P280-P301 + P312 + P330-P305 + P351 + P338-P337 + P313 | 
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves | 
| Hazard Codes | Xn:Harmful; | 
| Risk Phrases | R22 | 
| Safety Phrases | S26-S36/37 | 
| RIDADR | NONH for all modes of transport | 
| WGK Germany | 1 | 
| RTECS | OJ6419000 | 
| 
                                    
                                    In vitro and in vivo evaluation of a hydrogel reservoir as a continuous drug delivery system for inner ear treatment.
                                    
                                    
                                     PLoS ONE 9(8) , e104564, (2014) Fibrous tissue growth and loss of residual hearing after cochlear implantation can be reduced by application of the glucocorticoid dexamethasone-21-phosphate-disodium-salt (DEX). To date, sustained de...  | 
                                |
| 
                                    
                                    Crystallization and preliminary X-ray diffraction analysis of Leishmania major dihydroorotate dehydrogenase.
                                    
                                    
                                     Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 62(Pt 10) , 1049-51, (2006) Dihydroorotate dehydrogenases (DHODHs) are flavin-containing enzymes that catalyze the oxidation of L-dihydroorotate to orotate, the fourth step in the de novo pyrimidine nucleotide synthesis pathway....  | 
                                |
| 
                                    
                                    Electrochemical generation of gradients in surfactant concentration across microfluidic channels.
                                    
                                    
                                     Anal. Chem. 81(2) , 772-81, (2009) We report the generation and manipulation of spatial gradients in surfactant and micelle concentration across microfluidic channels by combining use of a redox-active surfactant with electrochemical m...  | 
                                
| Dilithium sulfate | 
| Lithium sulfate (2:1) | 
| UNII-919XA137JK | 
| Sulfuric acid dilithium salt | 
| LITHIUM SULPHATE | 
| MFCD00011086 | 
| EINECS 233-820-4 | 
| Lithium Sulfate | 
| dilithium,sulfate | 
| Sulfuric acid, lithium salt (1:2) |